GOLD COPD Assessment

COPD spirometric grade (1–4) and ABE group
For confirmed COPD (post-bronchodilator FEV1/FVC < 0.70). Exacerbation history is over the past 12 months.
Post-bronchodilator FEV1 (% predicted) %
Exacerbations in the past year
Symptom burden
Enter the FEV1 % predicted

About this score

When to use

Grades COPD by spirometry (GOLD 1–4 from post-bronchodilator FEV₁ % predicted) and assigns the ABE group from symptoms and exacerbation history. ⁦[1, 2]⁩

Pearls and pitfalls

• Spirometric grades: GOLD 1 FEV₁ 80% predicted or more, GOLD 2 50–79%, GOLD 3 30–49%, GOLD 4 below 30%, in a patient with FEV₁/FVC below 0.70. ⁦[2]⁩
• Since 2017 the spirometric grade and the symptom-and-exacerbation group are assessed separately; the 2023 report uses groups A and B for few exacerbations (by symptom burden) and E for 2 or more moderate exacerbations or 1 leading to hospitalisation. ⁦[2, 1]⁩
Summarised from the numbered sources under Evidence. Check the source before relying on a statement.
Evidence
[1] Original publication
Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Introduced the ABE assessment: spirometric grade 1–4 from post-bronchodilator FEV1 % predicted, and groups A/B (few exacerbations, by symptom burden) or E (≥ 2 moderate exacerbations or ≥ 1 leading to hospitalisation).
European Respiratory Journal, 2023
Open source
[2] Guideline
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Spirometric grades: GOLD 1 FEV1 ≥ 80% predicted, GOLD 2 50–79%, GOLD 3 30–49%, GOLD 4 < 30%, in a patient with FEV1/FVC < 0.70.
American Journal of Respiratory and Critical Care Medicine, 2017
Open source
Last reviewed: 2026-09
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.
Support the developer
MedScore is free on the web and made by a medical student. If it helps you, you can support its development.
Support MedScore